CFTR-France

Variant details:
Name	NM_000492.4:c.1209G>A
Protein name	NP_000483.3:p.(=)
Genomic name (hg19)	chr7:g.117182162G>A UCSC
Genomic name (hg38)	chr7:g.117542108G>A UCSC
#Exon/intron	exon 9
Legacy Name	E403E (1341G/A)
Class	disease-causing
Subclass	CF-causing
WT sequence	AGAATGTAACAGCCTTCTGGGAGGA G GTCAGAATTTTTAAAAAATTGTTTG
Mutant sequence	AGAATGTAACAGCCTTCTGGGAGGA A GTCAGAATTTTTAAAAAATTGTTTG

Other databases:
	Not found	dbSNP rs397508177

Pathogenicity predictors:
Not found

Modulator	FDA approval	EMA approval	in vitro / ex vivo data	clinical data
ELX-TEZ-IVA	yes	no	yes	no

No patient found in CFTR-NGS catalogue

2 patients carrying this variant are reported in CFTR-France:

TOTAL NUMBER OF PATIENTS	2
CF	2

Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing

Detailed genotypes:
Phenotype	Patient ID	Variant status	Additional variants
CF	2026	heterozygote	CF-causing - Trans
CF	2125	heterozygote	CF-causing - Trans

Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing

CFTR variants are clustered into five groups (click here for more details about the classification of variants):

CF-causing: when in trans with another CF-causing mutation, will result in CF.
CFTR-RD causing: when in trans with a CF-causing mutation, will result in CFTR-related disorders (CFTR-RD) such as chronic pancreatitis, bronchiectasis, CRS-NP (chronic rhinosinusitis with or without nasal polyposis) or CBAVD (congenital absence of vas deferens), according to Bombieri C et al., 2011.
Varying clinical consequence: when in trans with another CF-causing mutation, can either result in CF or in a CFTR-RD.
Non disease-causing: when in trans with a CF-causing mutation, will not cause CF, nor CFTR-RD.
VUS (Variant of unknown clinical significance): unclassified because of insufficient data.

Go to